Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

NCT00880750 PHASE1 COMPLETED Results posted

This study is being conducted to assess any potential differences in the absorption and excretion between two lanthanum carbonate formulations. This study is also being done to assess the safety and tolerability of the two lanthanum carbonate formulations.

Details

Lead sponsor	Shire
Phase	PHASE1
Status	COMPLETED
Enrolment	72
Start date	Wed Jan 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jun 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• End Stage Renal Disease

Interventions

• Lanthanum carbonate Granule Formulation
• Lanthanum carbonate Chewable Tablets (Fosrenol)

Countries

United States